Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE)...
Staff
Skylight Health Announces Closing of Tennessee Clinic with $2.2 Million in Revenue and Positive EBITDA
Company closes acquisition of Tennessee-based Perimeter Pain and Primary Care Clinic previously announced on December 3, 2020Tennessee-based Perimeter Pain and...
Sparta Capital Ltd. Announces Annual and Special Meeting Results
Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply...
Amarillo Biosciences, Ind. Enters into a Securities Purchase Agreement to Foster New Growth
AMARILLO, TX / ACCESSWIRE / December 30, 2020 / Amarillo Biosciences, Inc. ("we," "ABI" or the "Company"), (OTC PINK:AMAR), a...
IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator
Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating...
Beta Bionics Appoints Beth Brooke to Its Board as Independent Director
CONCORD, Mass.--(BUSINESS WIRE)--Beta Bionics, Inc. — a medical technology company developing the iLet®, the world’s first fully automated bionic pancreas...
Delaying Implementation of PMPRB’s Regulations an Opportunity to Protect Patient Access to Medicines and Vaccines Says Innovative Medicines Canada
OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Innovative Medicines Canada issued the following statement today in response to...
REPEAT – Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel
VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...
VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and Depression Disorders
Dr. Louis Monti, VistaGen’s Newly-Appointed Vice President, Translational Medicine, and Dr. Michael Liebowitz, VistaGen CNS Clinical and Regulatory Advisory Board...
Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021
FARMINGTON HILLS, Mich., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing...
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart ProceduresSAN CARLOS, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE)...
Assure Holdings Announces Early Final Payment of Neuro-Pro Monitoring Acquisition
DENVER, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
EDAP Announces End of the Year Focal One® Sales
Among December deals closed, two major US institutions have purchased Focal OneUniversity of California, San Francisco Medical Center and Cleveland...
Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today...
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines
NDA was Submitted in November in the Indication of MSI-H/dMMR Cancer, Including Colorectal and Gastric CancerSAN DIEGO, Dec. 30, 2020...
Algernon Pharmaceuticals Provides Year End Summary of Key Activities
VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
“USA Equities Corp (USAQ), Announces Revenues of $120,000 for the 4th Quarter of 2020 and Projects Revenues in excess of $300,000 for the 1st Quarter of 2021
WEST PALM BEACH, FL, Dec. 30, 2020 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”)...
Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK
Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK Oxford, UK – 30...
HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants
TUCSON, Ariz., Dec. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose...
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B
GAITHERSBURG, Md., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it...